Showing results (51-60 of 202) with videos related to
Sort By:
Pageof 21
Oncogene|February 3, 2018
PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activationYanlin Yu, Meng Dai, Andrew Lu, et al.Scientific Reports|May 18, 2016
Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfateWei Gao, Yongmei Xu, Jian Liu, et al.Current Protocols|June 17, 2022
Production and Purification of Shark and Camel Single-Domain Antibodies from Bacterial and Mammalian Cell Expression SystemsZhijian Duan, Jesse Buffington, Jessica Hong, et al.Advances in Cancer Research|August 12, 2022
Immunotherapy for hepatobiliary cancers: Emerging targets and translational advancesDan Li, Shaoli Lin, Jessica Hong, et al.STAR Protocols|November 26, 2021
Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse modelsNan Li, Rosa Nguyen, Carol J Thiele, et al.Pharmacology & Therapeutics|May 16, 2021
Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3Nan Li, Madeline R Spetz, Dan Li, et al.Proteoglycan Research|January 17, 2025
A proteomic atlas of glypican-3 interacting partners: Identification of alpha-fetoprotein and other extracellular proteins as potential immunotherapy targets in liver cancerYi-Fan Zhang, Shaoli Lin, Xiao Zhen, et al.The Journal of Biological Chemistry|October 20, 2004
In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxinMitchell Ho, Robert J Kreitman, Masanori Onda, et al.Current Protocols|January 3, 2023
Humanization of the Shark VNAR Single Domain Antibody Using CDR GraftingYi-Fan Zhang, Yaping Sun, Jessica Hong, et al.Trends in Cancer|October 25, 2018
Glypicans as Cancer Therapeutic TargetsNan Li, Wei Gao, Yi-Fan Zhang, et al.Pageof 21